Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AKAP13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR4271 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WBSCR27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLAMF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ROBO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00664 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC25A28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF316 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPSB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAXIP1-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOB3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASGRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAMPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on